MACROGENICS director reports option and RSU awards
MACROGENICS INC director David C. Stump reported routine equity compensation and an option exercise.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
MACROGENICS INC director David C. Stump reported routine equity compensation and an option exercise. On May 18, 2026, 3,750 restricted stock units (RSUs) vested and were converted into 3,750 shares of common stock, and he held 14,750 common shares directly afterward. On May 19, 2026, he received a grant of stock options for 22,000 shares at an exercise price of $4.52 per share, expiring on May 19, 2036, plus a new award of 3,750 RSUs. The filing notes that RSUs vest around the company’s annual meetings and that the new options vest monthly in 1/12th increments beginning one month after grant.
Insider Trade Summary
3,750 shares exercised/converted
Exercise
4 txns
Insider
STUMP DAVID C
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 3,750 | $0.00 | $0.00 |
| Grant/Award | Stock Option (right to buy) | 22,000 | $0.00 | $0.00 |
| Exercise | Restricted Stock Unit | 3,750 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,750 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Unit — 3,750 contracts (Direct);
Stock Option (right to buy) — 22,000 contracts (Direct);
Common Stock — 14,750 shares (Direct)
Footnotes (4)
- F1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
- F2. The RSUs vested on May 18, 2026, which was one day prior to the Issuer's 2026 Annual Meeting of Stockholders held on May 19, 2026.
- F3. The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier
- F4. The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.
Key Figures
Stock options granted: 22,000 shares
Option exercise price: $4.52 per share
RSUs granted: 3,750 units
+3 more
6 metrics
Stock options granted
22,000 shares
Stock Option (right to buy) granted May 19, 2026
Option exercise price
$4.52 per share
Exercise price for 22,000 stock options expiring May 19, 2036
RSUs granted
3,750 units
Restricted Stock Unit grant dated May 19, 2026
RSUs vested and converted
3,750 shares
RSUs vested May 18, 2026 and converted into common stock
Common shares held after vesting
14,750 shares
Direct common stock ownership after May 18, 2026 transaction
Option expiration date
May 19, 2036
Expiration for 22,000-share stock option grant
Key Terms
Restricted Stock Unit, Stock Option (right to buy, Annual Meeting of Stockholders, vest, +1 more
5 terms
Restricted Stock Unit financial
"Each restricted stock unit (RSU) represents a contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Option (right to buy financial
"security_title": "Stock Option (right to buy)""
Annual Meeting of Stockholders financial
"one day prior to the Issuer's 2026 Annual Meeting of Stockholders held on May 19, 2026"
vest financial
"The RSUs will vest one year after the date of grant, or the day prior"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion_or_exercise_price": "4.5200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did MACROGENICS (MGNX) director David C. Stump receive?
David C. Stump received stock options for 22,000 shares at a $4.52 exercise price and a grant of 3,750 restricted stock units. These awards represent routine director compensation linked to service on the MACROGENICS board and future vesting conditions.
What are the key terms of David C. Stump’s new MACROGENICS stock options?
The new stock options cover 22,000 shares of MACROGENICS common stock at a $4.52 exercise price and expire on May 19, 2036. They vest in monthly 1/12th increments, beginning one month after the grant date, according to the filing.
When did David C. Stump’s MACROGENICS restricted stock units vest?
The restricted stock units vested on May 18, 2026, one day before MACROGENICS’ 2026 Annual Meeting of Stockholders held on May 19, 2026. Each RSU represented a contingent right to receive one share of MACROGENICS common stock upon vesting.
How do future MACROGENICS RSU grants to David C. Stump vest?
The filing states that the RSUs will vest one year after the grant date, or on the day prior to MACROGENICS’ next annual meeting, if earlier. This schedule aligns director equity compensation with the company’s annual meeting cycle and board service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
